Back
Janux Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
JANX
Janux Therapeutics, Inc.
Last Price:
$13.10
Seasonality Move:
79.05%
7 Day Trial
ALL ACCESS PASS
$
7
Janux Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Janux Therapeutics, Inc. has on average historically risen by 49.2% based on the past 4 years of stock performance.
-
Janux Therapeutics, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Janux Therapeutics, Inc. Stock Undervalued?The current Janux Therapeutics, Inc. [JANX] share price is $13.08. The Score for JANX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Janux Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Janux Therapeutics, Inc. has on average historically risen by 49.2% based on the past 4 years of stock performance.
Janux Therapeutics, Inc. Stock Rating
Sell
36
Janux Therapeutics, Inc. (JANX)
is a Sell
Is Janux Therapeutics, Inc. overpriced?
-
Janux Therapeutics, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Janux Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
januxrx.com
52-Week Data
52-Week High:
38.42
52-Week Low:
12.12
Prediction Charts
Market Cap:
786.7M
Price in USD:
13.08
Volume:
813.6K
Beta:
2.93
Technical Analysis
SMA50:
13.94
SMA100:
20.18
SMA200:
22.30
52-Wk Change:
-64.81%
Stock Predictions
-
Is Janux Therapeutics, Inc. stock public?Yes, Janux Therapeutics, Inc. is a publicly traded company.
-
What is the Janux Therapeutics, Inc. stock quote today?The Janux Therapeutics, Inc. stock price is 13.08 USD today.
-
How to buy Janux Therapeutics, Inc. stock online?You can buy Janux Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-2 | 13.64 | 13.99 | 14.00 | 13.44 |
| Feb-3 | 13.91 | 13.80 | 14.16 | 13.35 |
| Feb-4 | 13.96 | 13.33 | 13.97 | 13.31 |
| Feb-5 | 13.20 | 12.18 | 13.36 | 12.12 |
| Feb-6 | 12.45 | 13.07 | 13.38 | 12.42 |
| Feb-9 | 13.03 | 13.27 | 13.45 | 12.75 |
| Feb-10 | 13.23 | 13.13 | 13.61 | 13.04 |
| Feb-11 | 13.15 | 13.11 | 13.31 | 12.74 |
| Feb-12 | 13.10 | 13.13 | 13.48 | 13.02 |
| Feb-13 | 13.25 | 13.14 | 13.79 | 13.08 |
| Feb-17 | 13.13 | 13.21 | 13.40 | 12.91 |
| Feb-18 | 13.18 | 13.21 | 13.58 | 13.16 |
| Feb-19 | 13.12 | 13.42 | 13.47 | 13.00 |
| Feb-20 | 13.29 | 13.08 | 13.39 | 13.02 |
Janux Therapeutics, Inc. Earnings
Janux Therapeutics, Inc. Earnings Report: Per Share Janux Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Janux Therapeutics, Inc. Forecast Revenue Growth
Janux Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Janux Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.83 per share.
* Janux Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.